Hemangioma natural history, complications and prognosis: Difference between revisions
No edit summary |
m (Bot: Removing from Primary care) |
||
| Line 23: | Line 23: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Disease]] | [[Category:Disease]] | ||
| Line 29: | Line 31: | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
Latest revision as of 22:01, 29 July 2020
|
Hemangioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemangioma natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Hemangioma natural history, complications and prognosis |
|
FDA on Hemangioma natural history, complications and prognosis |
|
CDC on Hemangioma natural history, complications and prognosis |
|
Hemangioma natural history, complications and prognosis in the news |
|
Blogs on Hemangioma natural history, complications and prognosis |
|
Risk calculators and risk factors for Hemangioma natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
If left untreated, 20% of patients with hemangioma may progress to develop ulceration, hemorrhage, infection, and high output cardiac failure. Common complications of hemangioma include ischemia, necrosis, ulceration, and bleeding. Prognosis is generally good.
Natural history
Hemangiomas are vascular tumors that are rarely apparent at birth, grow rapidly during the first six months of life, involute with time and do not necessarily infiltrate but can sometimes be destructive.[1][2]
Complications
Rapid growth of hemangiomas can lead to exhaustion of blood supply with resulting:[1]
Ophthalmic complications
Common complications of infantile hemangioma include:[3]
- Amblyopia
- Strabismus
- Proptosis
- Exposure keratopathy
- Compressive optic neuropathy
Prognosis
Hemangioma generally has a good prognosis and is cosidered as a benign condition.
References
- ↑ 1.0 1.1 Richter, Gresham T.; Friedman, Adva B. (2012). "Hemangiomas and Vascular Malformations: Current Theory and Management". International Journal of Pediatrics. 2012: 1–10. doi:10.1155/2012/645678. ISSN 1687-9740.
- ↑ Hassan, Basheir A.; Shreef, Khalid S. (2014). "Propranolol in Treatment of Huge and Complicated Infantile Hemangiomas in Egyptian Children". Dermatology Research and Practice. 2014: 1–5. doi:10.1155/2014/541810. ISSN 1687-6105.
- ↑ Callahan, Alison B.; Yoon, Michael K. (2012). "Infantile hemangiomas: A review". Saudi Journal of Ophthalmology. 26 (3): 283–291. doi:10.1016/j.sjopt.2012.05.004. ISSN 1319-4534.